Wednesday, January 5, 2022 / by Michelle Genolos
No reliable biomarker for predicting COVID-19 and MIS-C severity was available until the Children’s Healthcare of Atlanta Pediatric Neurotrauma Lab serendipitously discovered elevated levels of plasma osteopontin, an inflammatory biomarker they use to follow traumatic brain injuries (TBI) and concussions, were also elevated in COVID-19 positive and MIS-C patients.
The Carter Team prides itself on giving back to the community.
We have partnered with Children's healthcare to help and provide service to families who have been hit with childhood illness.
As always, we thank all of our clients for supporting us by sending us referrals so that we can continue to make a difference in a child's life.♥♥♥